Portal de Periódicos da CAPES

Annexin II: A Novel Mediator of Cell Surface Plasmin Generation

1997; Wiley; Volume: 811; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1997.tb52013.x

1749-6632

Katherine A. Hajjar, Jill S. Menell,

Protease and Inhibitor Mechanisms

Annals of the New York Academy of SciencesVolume 811, Issue 1 p. 337-349 Annexin II: A Novel Mediator of Cell Surface Plasmin Generation KATHERINE A. HAJJAR, KATHERINE A. HAJJAR Cornell University Medical College, 1300 York Avenue—Box 45, New York, New York 10021Search for more papers by this authorJILL S. MENELL, JILL S. MENELL Cornell University Medical College, 1300 York Avenue—Box 45, New York, New York 10021Search for more papers by this author KATHERINE A. HAJJAR, KATHERINE A. HAJJAR Cornell University Medical College, 1300 York Avenue—Box 45, New York, New York 10021Search for more papers by this authorJILL S. MENELL, JILL S. MENELL Cornell University Medical College, 1300 York Avenue—Box 45, New York, New York 10021Search for more papers by this author First published: 17 December 2006 https://doi.org/10.1111/j.1749-6632.1997.tb52013.xCitations: 45Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Hajjar, K. 1995. Changing concepts in fibrinolysis. Curr. Opin. Hematol. 2: 345– 350. 2 Hajjar, K. A. 1995. Cellular receptors in the regulation of plasmin generation. Thromb. Haemost. 74: 294– 301. 3 Levin, E. G. & D. J. Loskutoff. 1982. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J. Cell Biol. 94: 631– 636. 4 Loskutoff, D. J. & T. S. Edgington. 1977. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc. Natl. Acad. Sci. USA. 74: 3903– 3907. 5 Hajjar, K. A., P. C. Harpel, E. A. Jaffe & R. L. Nachman. 1986. Binding of plasminogen to cultured human endothelial cells. J. Biol. Chem. 261: 11656– 11662. 6 Hajjar, K. A., N. M. Hamel, P. C. Harpel & R. L. Nachman. 1987. Binding of tissue plasminogen activator to cultured human endothelial cells. J. Clin. Invest. 80: 1712– 1719. 7 Hajjar, K. A. & R. L. Nachman. 1988. Endothelial cell-mediated conversion of gluplasminogen to lys-plasminogen: further evidence for assembly of the fibrinolytic system on the endothelial cell surface. J. Clin. Invest. 82: 1769– 1778. 8 Lucas, M. A., L. J. Fretto & P. A. McKee. 1983. The binding of human plasminogen to fibrin and fibrinogen. J. Biol. Chem. 258: 4249– 4256. 9 Hoylaerts, M., D. C. Rijken, H. R. Lijnen & D. Collen. 1982. Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin. J. Biol. Chem. 257: 2912– 2929. 10 Markus, G., J. L. Evers & G. H. Hobika. 1978. Comparison of some properties of native (glu) and modified (lys) human plasminogen. J. Biol. Chem. 253: 733– 739. 11 Markus, G., R. L. Priore & F. C. Wissler. 1979. The binding of tranexamic acid to native (glu) and modified (lys) human plasminogen and its effect on conformation. J. Biol. Chem. 254: 1211– 1216. 12 Hajjar, K. A. & N. M. Hamel. 1990. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. J. Biol. Chem. 265: 2908– 2916. 13 Hajjar, K. A. 1991. The endothelial cell tissue plasminogen activator receptor: specific interaction with plasminogen. J. Biol. Chem. 266: 21962– 21970. 14 Hajjar, K. A., A. T. Jacovina & J. Chacko. 1994. An endothelial cell receptor for plasminogen and tissue plasminogen activator: I. Identity with annexin II. J. Biol. Chem. 269: 21191– 21197. 15 Huang, K., B. P. Wallner, R. J. Mattaliano, R. Tizard, C. Burne, A. Frey, C. Hession, P. McGray, L. K. Sinclair, E. P. Chow, J. L. Browning, K. L. Ramachandran, J. Tang, J. E. Smart & R. B. Pepinsky. 1986. Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60 v-src and of the epidermal growth factor receptor/kinase. Cell 46: 191– 199. 16 Raynal, P. & H. B. Pollard. 1994. Annexins: the problem of assessing the biologic role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim. Biophys. Acta 1197: 63– 93. 17 Swairjo, M. A. & B. A. Seaton. 1994. Annexin structure and membrane interactions: A molecular perspective. Ann. Rev. Biophys. Biomol. Struct. 23: 193– 213. 18 Chung, C. Y. & H. P. Erickson. 1994. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J. Cell Biol. 126: 539– 548. 19 Wright, J. F., A. Kurosky & S. Wasi. 1994. An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem. Biophys. Res. Commun. 198: 983– 989. 20 Huber, R., R. Berendes, A. Burger, M. Schneider, A. Karshikov & H. Luecke. 1992. Crystal and molecular structure of human annexin V after refinement: implications for structure, membrane binding and ion channel formation of the annexin family of proteins. J. Mol. Biol. 223: 683– 704. 21 Hajjar, K. A., C. A. Guevara, E. Lev, K. Downing & J. Chacko. 1996. Interaction of the fibrinolytic, annexin II, with the endothelial cell surface: Essential role of endonexin repeat 2. J. Biol. Chem. 271: 21652– 21659. 22 Cesarman, G. M., C. A. Guevara & K. A. Hajjar. 1994. An endothelial cell receptor for plasminogen/tissue plasminogen activator: II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J. Biol. Chem. 269: 21198– 21203. 23 McLean, J. W., J. E. Tomlinson, W. J. Kuang, D. L. Eaton, E. Y. Chen, G. M. Fless, A. M. Scanu & R. M. Lawn. 1987. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330: 132– 137. 24 Hajjar, K. A., D. Gavish, J. Breslow & R. L. Nachman. 1989. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 339: 303– 305. 25 Mudd, H., F. Skovby, H. L. Levy, K. D. Pettigrew, B. Wilcken, R. E. Pyeritz, G. Andrea, G. H. J. Boers, I. L. Bromberg, R. Cerone, B. Fowler, H. Grobe, H. Schmidt & L. Schweitzer. 1985. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am. J. Hum. Gen. 37: 1– 31. 26 Hajjar, K. A. 1993. Homocysteine-induced modulation of tissue plasminogen activator to its endothelial cell membrane receptor. J. Clin. Invest. 91: 2873– 2879. 27 Menell, J. S., G. M. Cesarman, M. A. McLaughlin, E. Lev & K. A. Hajjar. 1995. Annexin II: potential role in the coagulopathy of promyelocytic leukemia. J. Invest. Med. 43: 376A. 28 Falcone, D. J., W. Borth, J. Matthew, C. Guevara & K. A. Hajjar. 1995. Annexin II is a plasminogen receptor on THP-1 macrophages. FASEB J. 9: 2388. 29 Munson, P. J. & D. Rodbard. 1980. LIGAND: A versatile computerized approach for characterization of ligand-binding sites. Anal. Biochem. 107: 220– 239. 30 Moss, S. E. 1992. The Annexins. In The Annexins. S. E. Moss, Ed.: 1– 9. Portland Press, Ltd. London . Citing Literature Volume811, Issue1Atherosclerosis IVApril 1997Pages 337-349 ReferencesRelatedInformation